Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
san francisco
3
×
san francisco blog main
3
×
san francisco top stories
clinical trials
seattle blog main
seattle top stories
aimmune therapeutics
allergy
amgen
anaphylaxis
andrew oxtoby
biobucks
boulder/denver blog main
boulder/denver top stories
calistoga pharmaceuticals
cancer
cancer drugs
car-t immunotherapy
checkpoint inhibitors
cobimetinib
daniel edelman
deals
detroit blog main
detroit top stories
eosinophilic esophagitis
fda
food allergy
gilead sciences
idelalisib
immuno-oncology
immunotherapy
indiana blog main
indiana top stories
investing
What
drug
3
×
cancer
therapeutics
adding
agency
aimmune
allergy
approval
approved
awarded
bets
boost
despite
developed
expensive
family
far
fda
friday
gilead
hardest
hit
hottest
hunters
immunotherapy
ipo
late
medicines
million
oral
paying
peanut
pipeline
program
proteins
ras
reels
research
revolution
sciences
Language
unset
Current search:
drug
×
" san francisco "
×
" san francisco blog main "
×
" boston top stories "
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
